Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunqin Deng

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Thorax|November 18, 2023
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortalitySteven D Nathan, Shilpa Johri, Joanna M Joly, et al.
The Lancet. Neurology|January 8, 2008
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trialRichard A C Hughes, Peter Donofrio, Vera Bril, et al.
Archives of Neurology|May 12, 2010
Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathyNorman Latov, Chunqin Deng, Marinos C Dalakas, et al.
Journal of the Peripheral Nervous System : JPNS|November 3, 2010
Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE studyIngemar S J Merkies, Richard A C Hughes, Peter Donofrio, et al.
Muscle & Nerve|March 5, 2009
Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIVVera Bril, Hans Katzberg, Peter Donofrio, et al.
Chest|September 17, 2022
Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical OutcomesSteven D Nathan, Chunqin Deng, Christopher S King, et al.
Muscle & Nerve|July 29, 2010
Electrophysiologic correlations with clinical outcomes in CIDPVera Bril, Marta Banach, Marinos C Dalakas, et al.
The European Respiratory Journal|April 20, 2023
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension studyAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
The New England Journal of Medicine|January 13, 2021
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung DiseaseAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
BMJ Open Respiratory Research|March 22, 2024
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE studyJason Weatherald, Steven D Nathan, Karim El-Kersh, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Thorax|November 18, 2023
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortalitySteven D Nathan, Shilpa Johri, Joanna M Joly, et al.
The Lancet. Neurology|January 8, 2008
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trialRichard A C Hughes, Peter Donofrio, Vera Bril, et al.
Archives of Neurology|May 12, 2010
Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathyNorman Latov, Chunqin Deng, Marinos C Dalakas, et al.
Journal of the Peripheral Nervous System : JPNS|November 3, 2010
Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE studyIngemar S J Merkies, Richard A C Hughes, Peter Donofrio, et al.
Muscle & Nerve|March 5, 2009
Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIVVera Bril, Hans Katzberg, Peter Donofrio, et al.
Chest|September 17, 2022
Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical OutcomesSteven D Nathan, Chunqin Deng, Christopher S King, et al.
Muscle & Nerve|July 29, 2010
Electrophysiologic correlations with clinical outcomes in CIDPVera Bril, Marta Banach, Marinos C Dalakas, et al.
The European Respiratory Journal|April 20, 2023
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension studyAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
The New England Journal of Medicine|January 13, 2021
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung DiseaseAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
BMJ Open Respiratory Research|March 22, 2024
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE studyJason Weatherald, Steven D Nathan, Karim El-Kersh, et al.
Pageof 3